A computer model to simulate family history of breast/ovarian cancer in BRCA1 mutation carriers

Mathematical Biosciences

Volumn 171, Issue 1, 2001, Pages 99-111

  Bajdik, C D ^a,b   Raboud, J M ^a,c   Schechter, M T ^a,c   McGillivray, B C ^a,d   Gallagher, R P ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

^c Canadian HIV Trials Network   (Canada)

^d BC CHILDREN S HOSPITAL   (Canada)

Author keywords

Breast cancer; Familial disease; Genetic predisposition; Ovarian cancer; Simulation model

Indexed keywords

COMPUTER SIMULATION; EPIDEMIOLOGY; GENES; TUMORS;

MUTATION CARRIERS;

ONCOLOGY;

ARTICLE; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; COMPUTER MODEL; GENE MUTATION; GENETIC PREDISPOSITION; MEDICAL ETHICS; ONCOGENE; OVARY CANCER; SIMULATION;

ADULT; BREAST NEOPLASMS; BRITISH COLUMBIA; COMPUTER SIMULATION; FAMILY HEALTH; FEMALE; GENES, BRCA1; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; MIDDLE AGED; MODELS, GENETIC; OVARIAN NEOPLASMS; PEDIGREE;

EID: 0035006441     PISSN: 00255564     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-5564(01)00052-9     Document Type: Article

References (27)

1. Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history
2. Determining carrier probabilities for breast cancer susceptibility gene BRCA1 and BRCA2
3. BRCA1 sequence analysis in women at high risk for susceptibility mutations
4. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer
5. BRCA1, BRCA2, and hereditary nonpolyposis colorectal cancer gene mutations in an unselected ovarian cancer population: Relationship to family history and for genetic testing
6. The contribution of germline BRCA1 and BRCA2 mutations to familial ovarian cancer: No evidence for other ovarian cancer susceptibility genes
7. Risk factors for detecting germline BRCA1 and BRCA2 founder mutations in Ashkenazi Jewish women with breast or ovarian cancer
8. The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews
9. The accuracy of patient reports of a family history of cancer
10. Accuracy of family cancer history in breast cancer patients
11. Validation of family history of cancer in deceased family members
12. Controlled trial of pretest education approaches to enhance informed decision making for BRCAI gene testing
13. Public health aspects of breast cancer gene testing in Canada. Part I: Risks and interventions
14. Public health aspects of breast cancer gene testing in Canada. Part II: Selection for and effects of testing
15. Public health aspects of breast cancer gene testing in Canada. Part III: A model of potential need demand
16. Statistcis Canada, life tables, Canada and Provinces, 1990-92
17. Statistcis Canada, births and deaths, 1995
18. Frequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patients
19. The breast cancer linkage consortium, breast and ovarian cancer incidence in BRCA1 mutations carriers
20. Genetic analysis of breast cancer in the cancer and steroid hormone study
21. Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: Results from three US population-based case-control studies of ovarian cancer
22. Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2
23. Estimating genetic influence on disease from population-based case-control data: Application to cancers of the breast and ovary
24. Modeling hazard functions in families
25. Why are the majority of hereditary cases of early-onset breast cancer sporadic? A simulation study